Influence of the MTHFR C677T polymorphism on magnetic resonance imaging hyperintensity volume and cognition in geriatric depression

American Journal of Geriatric Psychiatry

Volumn 17, Issue 10, 2009, Pages 847-855

  Hong, Edmund D ^a   Taylor, Warren D ^b   McQuoid, Douglas R ^b   Potter, Guy G ^b   Payne, Martha E ^b   Ashley Koch, Allison ^c   Steffens, David C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Depression; Elderly; Folate; Homocysteine; MTHFR polymorphism; White matter lesion

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ALLELE; ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENOTYPE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; TASK PERFORMANCE; WHITE MATTER;

EID: 70349679115     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181aad5b2     Document Type: Article

References (42)

1. Kim JM, Stewart R, Kim SW, et al: Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry 2008; 192:268-274
2. Mischoulon D, Raab MF: The role of folate in depression and dementia. J Clin Psychiatr 2007; 68:28-33
3. Bottiglieri T, Hyland K, Reynolds EH: The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994; 48:137-152 (Pubitemid 24260350)
4. Obeid R, McCaddon A, Herrmann W: The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 2007; 45:1590-1606
5. Cantoni GL, Mudd SH, Andreoli V: Affective disorders and Sadenosylmethionine: A new hypothesis. Trends Neurosci 1989; 12:319-324
6. Frankenburg FR: The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry 2007; 15:146-160
7. Ueland PM, Hustad S, Schneede J, et al: Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22:195-201
8. Lewis SJ, Lawlor DA, Davey Smith G, et al: The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 2006; 11:352-360
9. Bjelland I, Tell GS, Vollset SE, et al: Folate, vitamin B12, homocysteine, and the MTHFR 677C-T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60:618-626
10. Almeida OP, Flicker L, Lautenschlager NT, et al: Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Neurobiol Aging 2005; 26:251-257
11. Chen CS, Tsai JC, Tsang HY, et al: Homocysteine levels, MontHFR C677T genotype, and MRI hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry 2005; 13:869-875
12. Gilbody S, Lewis S, Lightfoot T: Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am J Epidemiol 2007; 165:1-13
13. Zintzaras E: C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: A meta-analysis of genetic association studies. Psychiatr Genet 2006; 47:589-593
14. Gaysina D, Cohen S, Craddock N, et al: No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: Results of the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2007; 147B:699-706
15. Almedia OP, McCaul K, Hankey GJ, et al: Homocysteine and depression in later life. Arch Gen Psychiatry 2008; 65:1286-1294
16. Sneed JR, Rindskopf D, Steffens DC, et al: The vascular depression subtype: Evidence of internal validity. Biol Psychiatry 2008; 64:491-497
17. Iosifescu DV, Papakostas GI, Lyoo IK, et al: Brain MRI white matter hyperintensities and one-carbon cycle metabolism in nongeriatric outpatients with major depressive disorder. Psychiatry Res 2005; 140:291-299
18. Kohara K, Fujisawa M, Ando F, et al: MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Stroke 2003; 34:1130-1135
19. Elkins JS, Johnston SC, Ziv E, et al: Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in older women. Am J Epidemiol 2007; 166:672-678
20. Bathum L, von Bornemann Hjelmborg J, Christiansen L, et al: Methylenetetrahydrofolate reductase 677C-T and methionine synthase 2756A-G mutations: No impact on survival, cognitive functioning, or cognitive decline in nonagenarians. J Gerontol A Biol Sci Med Sci 2007; 62:196-201
21. Steffens DC, Welsh-Bohmer KA, Burke JR, et al: Methodology and preliminary results from the neurocognitive outcomes of depression in the elderly study. J Geriatr Psychiatry Neurol 2004; 17: 202-211
22. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
23. Landerman R, George LK, Campbell RT, et al: Alternative models of the stress buffering hypothesis. Am J Community Psychol 1989; 17:626-642
24. Robins LN, Helzer JE, Croughan J, et al: National Institute of Mental Health diagnostic interview schedule. Arch Gen Psychiatry 1981; 38:381-389
25. Rimmler J, McDowell JG, Slotterback BD, et al: Development of a data coordinating center (DCC): Data quality control for complex disease studies. Am J Hum Genet 1998; suppl 63:A240
26. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113
27. Payne ME, Fetzer DL, MacFall JR, et al: Development of a semiautomated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res 2002; 115: 63-77
28. Reitan RM: Trail Making Test: Manual for Administration and Scoring. Tuscon, AZ, Reitan Neuropsychological Laboratory, 1992
29. Smith A: Symbol Digit Modalities Test-Manual. Los Angeles, CA, Western Psychological Services, 1982
30. Wechsler D: Wechsler Adult Intelligence Scale-Revised. San Antonio, TX, The Psychological Corporation, 1987
31. Benton A: Revised Visual Retention Test, 4th ed. New York, NY, The Psychological Corporation, 1974
32. Benton AL, Hamsher KD, Varney NR, et al: Contributions to Neuropsychological Assessment: A Clinical Manual. New York, NY, Oxford University Press, 1983
33. Lezak MD, Howieson DB, Loring DW: Neuropsychological Assessment. New York, NY, Oxford University Press, 2004
34. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141:1356-1364
35. Taylor WD, MacFall JR, Payne ME, et al: Greater MRI lesion volume in elderly depressed subjects than in control subjects. Psychiatry Res 2005; 30:1-7
36. Ilhan N, Kucuksu M, Kaman D, et al: The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 2008; 39:125-130
37. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al: Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002; 51:285-289
38. Bottiglieri T, Laundy M, Crellin R, et al: Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69:228-232
39. Tolmunen T, Hintikka J, Voutilainen S: Association between depressive symptoms and serum concentrations of homocysteine in men: A population study. Am J Clin Nutr 2004; 80:1574-1578
40. Tiemeier H, van Tuijl HR, Hofman A, et al: Vitamin B12, folate, and homocysteine in depression: The Rotterdam Study. Am J Psychiatry 2002; 159:2099-2101
41. Krasinski SD, Russell RM, Samloff IM, et al: Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators. J Am Geriatr Soc 1986; 34:800-806
42. Saltzman JR, Russell RM: The aging gut. Nutritional issues. Gastroenterol Clin North Am 1998; 27:309-324